Ann: Regulatory Approval for Remplir Nerve Repair Device, page-65

I've said time and time again on this site, buy in on the lower priced wanes like now, not on the announcements if you like the company's prospects. Look at the volumes vs price action in the past five days. Its ludicrous the petty volumes that went through today, vs the massive amounts on the Remplir approval Monday. You are retail, you don't need large volume days to buy-in. I bought a little more today and yesterday, paying $0.435 (some algorithm ran my $0.43 bid on open), rather than the $0.52 some punters will have paid on Monday. Whilst the company is slow on approvals etc, they consistently announce positive results, unlike other bio-techs I could name.

This is partly why the stock never holds it moves. Massive buyers on spikes who then bottle it when the move doesn't hold. Becomes self fulfilling as they lose their conviction and sell out in thinner volumes. I get criticized on here a lot. I am not on of the fool punters putting rockets on here on past announcement spikes who have long since sold out at a loss and disappeared from these forums.

Its bio-tech. Slow and steady buying the go for better average buy-in.

You have Remplir now being sold in Oz, Straite in EU/USA/Oz, so revenues should continue to grow. I've spoken to two Aussie nerve specialists who are keen and no doubt far more are following the recent conference. Remplir moving towards approval in the massive US mkt. Full recruitment in the ATI vs surgery RCT (and that's OCC owned data, so likely and initial results analysis on full recruitment) and more data coming on the J&J ATI RCT, etc, etc. Buy between the announcements, and if you don't want to hold the company anymore, sell out on the spikes, is a clearly illustrated better strategy.

I am fed up being polite. Look at all the dopes who sold down to $0.36 recently when I had been saying on here for weeks hat a CelGro Nerve (Remplir) was imminent. If you are looking to get out (I certainly am not), as smaller retail you could have sold as much as you want $0.50+ on Monday, instead people are selling at $0.43. Stupid.

(this is not investement advice, its simple common sense looking at share price vs volumes)